By Priscila Mayumi Kashiwabara

We are honored to announce that three members of our team have been elected Lexology Legal Influencers 2023 in the Central and … Kasznar Leonardos is recognized on the Lexology Legal Influencer 2023

We, from Kasznar Leonardos, were represented at the AIPPI World Conference held in Istanbul, Turkey. Our partners, João Luís Vianna, Gabriel Leonardos, … Kasznar Leonardos represented at the AIPPI World Congress 2023

The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil … Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

The World Intellectual Property Organization (WIPO) has just published this year’s edition of its Global Innovation Index (GII). Among the 132 economies included in … Brazil climbs five positions and reaches Top 50 in WIPO’S Global Innovation Index 2023 Ranking

Check out the article “On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brasil”,  published on IAM Media, authored by … On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil

Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good … New subject codes for filing applications for GMP certification for biological products industries

Check out the article “Cannabis and IP: Nurturing innovation in Brazil’s life sciences industry”, authored by Priscila Kashiwabara and Luan Scalzitti and … Cannabis and IP: Nurturing innovation in Brazil’s Life Sciences industry

It is with great honor that we share our ranking in the IAM Patent 1000 2023. In addition to being recognized as … Kasznar Leonardos was ranked on IAM Patent 1000

On May 9, 2023, the BPTO released the INPI/CPAPD technical opinion No. 01/2023, which provides guidance on the patentability of inventions related … The Brazilian PTO published a new technical opinion regarding the patentability of inventions related to transgenic plants

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine

Our partners Priscila Kashiwabara and Viviane Trojan are set to attend BIO Europe Spring, which will be taking place from March 20-22, … Kasznar Leonardos will be at BIO Europe Spring

Our partner Priscila Kashiwabara and specialists Breno Alves and Gabriel Cavalcante published the article “Sustainable agriculture, green technologies and IP in Brazil” in the Global Patent Prosecution Guide … Sustainable agriculture, green technologies and IP in Brazil

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant … Protecting Plant Varieties in Brazil for FloraCulture Magazine

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission … INPI publishes communication on new sequence listing standard for patent applications in Brazil

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving … Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events